Liver regeneration in fatty liver disease: can metabolomics shed light on the contribution of the gut microbiome?
作者信息
Jokisch Florian, Geyer Laura Jennifer Marie, Janssen Klaus-Peter
机构信息
Department of Surgery, Technical University of Munich, School of Medicine and Health, Munich, Germany.
Department of Surgery, Technical University of Munich, School of Medicine and Health, Munich, Germany.
出版信息
EBioMedicine. 2025 Feb;112:105552. doi: 10.1016/j.ebiom.2024.105552. Epub 2025 Jan 10.
Abstract
摘要
相似文献
1
Liver regeneration in fatty liver disease: can metabolomics shed light on the contribution of the gut microbiome?脂肪性肝病中的肝脏再生：代谢组学能否揭示肠道微生物群的作用？
EBioMedicine. 2025 Feb;112:105552. doi: 10.1016/j.ebiom.2024.105552. Epub 2025 Jan 10.
2
Microbiome and metabolomics reveal the effect of gut microbiota on liver regeneration of fatty liver disease.微生物组学和代谢组学揭示肠道微生物群对脂肪肝疾病肝脏再生的影响。
EBioMedicine. 2025 Jan;111:105482. doi: 10.1016/j.ebiom.2024.105482. Epub 2024 Dec 6.
3
Gut microbiome and nonalcoholic fatty liver disease.肠道微生物群与非酒精性脂肪性肝病
Hepatobiliary Pancreat Dis Int. 2023 Oct;22(5):444-451. doi: 10.1016/j.hbpd.2023.06.006. Epub 2023 Jun 3.
4
Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response.慢性乙型肝炎感染相关肝病中肠道微生物组和代谢组学的改变及其对外周免疫反应的影响。
Gut Microbes. 2023 Jan-Dec;15(1):2155018. doi: 10.1080/19490976.2022.2155018.
5
Integrative metabolomics highlights gut microbiota metabolites as novel NAFLD-related candidate biomarkers in children.整合代谢组学强调肠道微生物群代谢物作为儿童非酒精性脂肪性肝病相关的新型候选生物标志物。
Microbiol Spectr. 2024 Apr 2;12(4):e0523022. doi: 10.1128/spectrum.05230-22. Epub 2024 Mar 6.
6
C-Stable isotope resolved metabolomics uncovers dynamic biochemical landscape of gut microbiome-host organ communications in mice.C-稳定同位素分辨代谢组学揭示了小鼠肠道微生物组-宿主器官通讯的动态生化景观。
Microbiome. 2024 May 15;12(1):90. doi: 10.1186/s40168-024-01808-x.
7
Zuogui-Jiangtang-Qinggan-Fang alleviates high-fat diet-induced type 2 diabetes mellitus with non-alcoholic fatty liver disease by modulating gut microbiome-metabolites-short chain fatty acid composition.左归丸加味方通过调节肠道微生物群-代谢物-短链脂肪酸组成，改善高脂饮食诱导的2型糖尿病合并非酒精性脂肪性肝病。
Biomed Pharmacother. 2023 Jan;157:114002. doi: 10.1016/j.biopha.2022.114002. Epub 2022 Nov 18.
8
Gut microbiome and metabolic response in non-alcoholic fatty liver disease.肠道微生物组与非酒精性脂肪性肝病的代谢反应。
Clin Chim Acta. 2021 Dec;523:304-314. doi: 10.1016/j.cca.2021.10.014. Epub 2021 Oct 16.
9
Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanism and Application of Metabolomics.肠道微生物群与非酒精性脂肪性肝病：代谢组学的作用机制及应用见解
Int J Mol Sci. 2016 Mar 15;17(3):300. doi: 10.3390/ijms17030300.
10
Iron status influences non-alcoholic fatty liver disease in obesity through the gut microbiome.铁状态通过肠道微生物群影响肥胖的非酒精性脂肪肝疾病。
Microbiome. 2021 May 7;9(1):104. doi: 10.1186/s40168-021-01052-7.
本文引用的文献
1
Microbiome and metabolomics reveal the effect of gut microbiota on liver regeneration of fatty liver disease.微生物组学和代谢组学揭示肠道微生物群对脂肪肝疾病肝脏再生的影响。
EBioMedicine. 2025 Jan;111:105482. doi: 10.1016/j.ebiom.2024.105482. Epub 2024 Dec 6.
2
Gut microbiota promote liver regeneration through hepatic membrane phospholipid biosynthesis.肠道微生物群通过肝脏膜磷脂生物合成促进肝脏再生。
J Hepatol. 2023 Apr;78(4):820-835. doi: 10.1016/j.jhep.2022.12.028. Epub 2023 Jan 18.
3
MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease.MAFLD：代谢相关脂肪性肝病的共识驱动命名建议。
Gastroenterology. 2020 May;158(7):1999-2014.e1. doi: 10.1053/j.gastro.2019.11.312. Epub 2020 Feb 8.
4
The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD).肠道微生物组与非酒精性脂肪性肝病（NAFLD）之间的联系。
Cell Mol Life Sci. 2019 Apr;76(8):1541-1558. doi: 10.1007/s00018-019-03011-w. Epub 2019 Jan 25.
5
Non-alcoholic fatty liver disease - A global public health perspective.非酒精性脂肪性肝病——全球公共卫生视角。
J Hepatol. 2019 Mar;70(3):531-544. doi: 10.1016/j.jhep.2018.10.033. Epub 2018 Nov 9.
6
Burden of liver diseases in the world.世界范围内的肝脏疾病负担。
J Hepatol. 2019 Jan;70(1):151-171. doi: 10.1016/j.jhep.2018.09.014. Epub 2018 Sep 26.
Zotero 插件